CureVac N.V.

CVAC · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income$190,881-$260,167-$249,155-$412,498
Dep. & Amort.$18,809$23,386$23,741$15,674
Deferred Tax$0$0-$1,583$199,023
Stock-Based Comp.$4,121$7,697$9,185$14,956
Change in WC-$163,963-$68,290-$125,563-$69,547
Other Non-Cash$52,003$29,487$57,198-$480,736
Operating Cash Flow$101,851-$267,887-$286,177-$733,128
Investing Activities
PP&E Inv.-$14,315-$52,320-$93,222-$127,901
Net Acquisitions$0$0-$277$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$4,129-$2,880-$5,199-$3,679
Investing Cash Flow-$18,444-$55,200-$93,499-$127,901
Financing Activities
Debt Repay.-$5,114-$5,193-$4,221-$28,183
Stock Issued$0$236,086$67,394$404,062
Stock Repurch.$0$0$0-$30,915
Dividends Paid$0$0$0$0
Other Fin. Act.$0$246$0$0
Financing Cash Flow-$5,114$230,893$63,173$344,964
Forex Effect$1,003-$1,151$836$4,936
Net Chg. in Cash$79,296-$93,345-$315,667-$511,129
Supplemental Information
Beg. Cash$402,452$495,797$811,464$1,322,593
End Cash$481,748$402,452$495,797$811,464
Free Cash Flow$83,407-$323,087-$379,399-$861,029